CN Patent

CN121194983A — 5'-膦酸酯修饰的核苷类似物及其制备的寡核苷酸

Assigned to Shanghai Bowang Pharmaceutical Co ltd · Expires 2025-12-23 · 0y expired

What this patent protects

涉及可用于5′修饰的核苷类似物以及由它们制备的寡核苷酸，更具体涉及可用于并入到寡核苷酸末端的修饰核苷及其类似物，可以结合到双链寡核苷酸(短干扰RNA)或单链寡核苷酸(例如反义寡核苷酸)中。预期提供的所述寡核苷酸与靶RNA的一部分杂交，从而导致所述靶RNA正常功能的丧失。

USPTO Abstract

涉及可用于5′修饰的核苷类似物以及由它们制备的寡核苷酸，更具体涉及可用于并入到寡核苷酸末端的修饰核苷及其类似物，可以结合到双链寡核苷酸(短干扰RNA)或单链寡核苷酸(例如反义寡核苷酸)中。预期提供的所述寡核苷酸与靶RNA的一部分杂交，从而导致所述靶RNA正常功能的丧失。

Drugs covered by this patent

Patent Metadata

Patent number
CN121194983A
Jurisdiction
CN
Classification
—
Expires
2025-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Bowang Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.